Skip to main content
Molecular Therapy. Nucleic Acids logoLink to Molecular Therapy. Nucleic Acids
. 2023 Oct 5;34:102048. doi: 10.1016/j.omtn.2023.102048

Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression

Hong-Yu Ma, Yang Li, Hui-Zi Yin, Hang Yin, Yuan-Yuan Qu, Qing-Yong Xu
PMCID: PMC10565844  PMID: 37829327

Main text

(Molecular Therapy: Nucleic Acids 22, December 2020; 640–656)

This article has been retracted at the request of the Editor-in-Chief. A third party communicated concerns of image reuse to the editorial office. Concerns were also posted to a Pubpeer thread: https://pubpeer.com/publications/64745FD0992EE7AD28B6E6D5F3E99B#1. Similarities were found between images in this article and an article in Cancer Cell International (Li et al., 2020, Cancer Cell Int. 20, 200, https://doi.org/10.1186/s12935-020-01261-4). Image analysis performed by the editorial office confirmed the finding of image reuse in Figure 1A of this article. Given these issues, the editors have lost faith in the findings presented in the article. This reuse (and in part misrepresentation) of data without appropriate attribution represents a severe abuse of the scientific publishing system. The authors disagree with this retraction.


Articles from Molecular Therapy. Nucleic Acids are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES